PDCD1 and neoplasm: One pre-clinical study demonstrated that the expression of ligands for PD-1 on a B cell tumor model rendered the CAR-T non-functional, and that knockout PD-1 on CAR-Ts improved clearance of PD-ligand expressing tumor cells compared to the standard CAR-T [47].